Sign in to continue:

Tuesday, February 24th, 2026

ContextLogic Holdings Inc. Files Form 8-K Current Report with SEC – Company Details, Address, and Filing Information (February 2026) 3 4 5





ContextLogic Holdings Inc. Announces Expiration of Rights Offering


ContextLogic Holdings Inc. Announces Expiration of Rights Offering

Date: February 23, 2026

Key Points from the Report

  • The rights offering subscription period for ContextLogic Holdings Inc. (the “Company”) expired on February 20, 2026, at 5:00 p.m. New York City time.
  • This rights offering (the “Rights Offering”) was previously announced and allowed holders of ContextLogic common stock to purchase up to an aggregate of 14,375,000 shares of common stock, par value \$0.0001 per share.
  • Unexercised subscription rights expired at the deadline and are now void and have no value.
  • The Company expects to file a further Current Report on Form 8-K on or around February 26, 2026, which will include the final results of the Rights Offering.
  • Any excess subscription payments received will be returned to the applicable holders by the Rights Agent via check, without any interest or deduction.
  • The shares purchased in the Rights Offering will be issued in uncertificated book-entry form.
  • The Company had previously entered into a backstop agreement with BCP Special Opportunities Fund III Originations LP, as outlined in a prior 8-K filing on December 11, 2025. This agreement provided certain purchase commitments in the event the Rights Offering was not fully subscribed.
  • As of the date of this report, the Company does not have any securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934 (i.e., no listed securities).
  • The Company is not classified as an emerging growth company as per the definitions under the Securities Act and Exchange Act.

Important Shareholder and Investor Information

  • Potential Share Dilution: Up to 14,375,000 new shares of ContextLogic common stock may be issued as a result of the Rights Offering, potentially diluting existing shareholders who did not exercise their rights.
  • Backstop Agreement: BCP Special Opportunities Fund III Originations LP is serving as a backstop, meaning it may acquire any unsubscribed shares, potentially becoming a significant shareholder or influencing control dynamics.
  • Unlisted Status: The Company currently has no active trading symbol and no securities listed on any exchange. This may affect liquidity and valuation transparency for investors.
  • Final Results Pending: The final allocation and outcome of the Rights Offering, including the exact number of shares issued and to whom, will be disclosed in a future SEC filing expected around February 26, 2026.
  • Refunds for Over-Subscription: If you overpaid during the Rights Offering, expect a refund by check from the Rights Agent, with no interest or deductions.

Potential Share Price Impact

  • The Rights Offering could significantly increase the number of outstanding shares, which may put downward pressure on share value due to dilution.
  • The involvement of BCP Special Opportunities Fund III as a backstop could signal external investor confidence, but may also raise questions about future strategic direction or control.
  • The lack of a trading symbol or exchange listing could limit liquidity for investors and may make it more challenging to ascertain fair market value of the shares.
  • Investors should closely monitor the upcoming 8-K filing for the final results, as the subscription rates and amount of shares ultimately issued may further inform the Company’s capital structure and investor base.

Additional Details

  • Any rights not exercised by the expiration date are now void and without value.
  • Shares issued through this offering will be in uncertificated, book-entry form, not physical certificates.
  • There are no new securities being registered for public trading at this time.
  • The Company’s President and Principal Executive Officer, Mark Ward, signed the report on behalf of ContextLogic Holdings Inc. on February 23, 2026.
Disclaimer: This article is for informational purposes only and does not constitute investment advice, an offer, or a solicitation to buy or sell any securities. Investors should review official filings with the U.S. Securities and Exchange Commission (SEC) and consult with financial advisors before making investment decisions. The information provided is based on public filings as of the dates indicated and may be subject to change or revision.




View ContextLogic Holdings Inc. Historical chart here



Axsome Therapeutics, Inc. Annual Report 2024: Innovative CNS Medicines, FDA Approvals, Pipeline, and Competitive Landscape

Axsome Therapeutics, Inc. 2025 Annual Report – Key Highlights for Investors Axsome Therapeutics, Inc. (AXSM) 2025 Annual Report – Investor Insights Overview Axsome Therapeutics, Inc. is a fully integrated biopharmaceutical company headquartered at One...

Easterly Government Properties, Inc. 2025 Annual 10-K Report Highlights: Real Estate Investment Trust Financials, Properties, and Major Customers

NIL Disclaimer: This article is provided for informational purposes only and does not constitute investment advice. Investors should conduct their own research or consult a financial advisor before making investment decisions. The author and...

HCW Biologics Announces $1.5 Million At-The-Market Offering to Advance Immunotherapy Clinical Trials

HCW Biologics Announces \$1.5 Million At-The-Market Follow-On Offering HCW Biologics Announces Pricing of \$1.5 Million Follow-On Offering and Warrant Exercise Price Reduction Key Highlights Offering Details: HCW Biologics Inc. (NASDAQ: HCWB), a clinical-stage biopharmaceutical...

   Ad